Enanta Pharmaceuticals, Inc (ENTA) Stock Price

14.82 ▲ +0.55 (+3.85%)
Open: 14.08 Vol: 0 Day's range: 14.08 - 14.84 Apr 14, 11:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ENTA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 14.80▲ 14.70▲ 14.54▲ 14.19▲ 13.36▲
MA10 14.67▲ 14.49▲ 14.38▲ 13.64▲ 13.47▲
MA20 14.47▲ 14.36▲ 14.19▲ 13.08▲ 13.79▲
MA50 14.35▲ 14.10▲ 13.74▲ 13.56▲ 10.67▲
MA100 14.21▲ 13.68▲ 13.10▲ 13.77▲ 10.07▲
MA200 13.99▲ 13.07▲ 13.29▲ 11.40▲ 20.30▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.048▲ 0.052▲ 0.043▲ 0.260▲ -0.135▼
RSI 74.800▲ 73.138▲ 76.092▲ 67.658▲ 61.937▲
STOCH 97.590▲ 88.026▲ 90.200▲ 92.673▲ 34.775    
WILL %R 0.000▲ 0.000▲ 0.000▲ 0.000▲ -21.120▲
CCI 96.014     149.239▲ 222.600▲ 143.119▲ 133.005▲
Latest Filters Detected On ENTA
▲ BREAK $ENTA Price Breaks 20 Days High Set Alert
▲ BREAK $ENTA Price Breaks 10 Days High Set Alert
CDL $ENTA Marubozu Candlestick Pattern Detected Set Alert
Enanta Pharmaceuticals, Inc News
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria
Monday, April 13, 2026 04:36 AM
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that the ...
Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID ...
Tuesday, April 07, 2026 04:20 AM
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that data ...
Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI)
Monday, March 30, 2026 04:01 AM
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that ...
ENTA historical stock data
date open high low close volume
14/04/26 14.08 14.85 14.08 14.85 26,862
13/04/26 14.09 14.42 13.93 14.27 71,983
10/04/26 13.94 14.41 13.85 14.11 227,552
09/04/26 13.67 14.12 13.43 13.95 108,334
08/04/26 13.81 14.00 13.56 13.77 76,940
07/04/26 13.19 13.47 12.84 13.43 91,753
06/04/26 13.17 13.59 12.80 13.25 115,597
02/04/26 12.66 13.26 12.61 13.14 112,823
01/04/26 12.76 13.32 12.144 12.97 202,061
31/03/26 12.43 12.76 12.235 12.63 107,548
Quote Details
52wk Low:4.96
52wk High:17.15
Vol:0
Avg Vol(3m):2.8M
1Y Chng:+143.84%
1M Chng:+0.88%
Add to Watch List
More Information
Index US Composite
Market Cap. 409.46M